4.5 Article

Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Masato Hasegawa et al.

ANNALS OF NEUROLOGY (2008)

Article Biochemistry & Molecular Biology

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Tetsuaki Arai et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Article Multidisciplinary Sciences

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Manuela Neumann et al.

SCIENCE (2006)

Review Biochemistry & Molecular Biology

Are ubiquitination pathways central to Parkinson's disease?

BI Giasson et al.

Article Biochemistry & Molecular Biology

Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease

S Keck et al.

JOURNAL OF NEUROCHEMISTRY (2003)

Article Psychiatry

Frontotemporal dementia

JS Snowden et al.

BRITISH JOURNAL OF PSYCHIATRY (2002)

Article Multidisciplinary Sciences

Impairment of the ubiquitin-proteasome system by protein aggregation

NF Bence et al.

SCIENCE (2001)

Article Biochemistry & Molecular Biology

Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping

E Buratti et al.

EMBO JOURNAL (2001)

Article Biochemistry & Molecular Biology

Impaired proteasome function in Alzheimer's disease

JN Keller et al.

JOURNAL OF NEUROCHEMISTRY (2000)